Products
16941 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 97.61 | 5.93 | 0.070 | 6 | 1 | -1.17% | -4.97% | -2.63% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 97.61 | 2.81 | 0.050 | 2.86 | 1 | -1.75% | -6.95% | -4.42% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 97.61 | 0.95 | 0.030 | 0.98 | 1 | -3.06% | -2.06% | -9.52% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 97.61 | 2.62 | 0.030 | 2.65 | 1 | -1.13% | 0.00% | -4.73% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 97.61 | 3.07 | 0.070 | 3.14 | 1 | -2.23% | -1.92% | -19.63% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 97.61 | 0.28 | 0.030 | 0.31 | 1 | -9.68% | -9.68% | -17.65% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 97.61 | 3.88 | 0.080 | 3.96 | 1 | -2.02% | -1.02% | -15.47% | 12 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1346000271 | Novo Nordisk | Constant Leverage | Long | ― | 441.799 | 0.051 | 0.003 | 0.054 | 1 | -5.56% | -13.56% | -42.70% | 9 Jul. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 441.799 | 0.12 | 0.020 | 0.14 | 1 | -14.29% | -20.00% | -47.83% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327897 | Novo Nordisk | Constant Leverage | Long | ― | 441.799 | 0.041 | 0.003 | 0.044 | 1 | -6.82% | -16.33% | -79.50% | 29 Jan. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 441.799 | 0.001 | ― | ― | 1 | 0.00% | -50.00% | 0.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 441.799 | 0.001 | ― | ― | 1 | 0.00% | -66.67% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327889 | Novo Nordisk | Constant Leverage | Long | ― | 441.799 | 0.4 | 0.030 | 0.43 | 1 | -6.98% | -11.11% | -60.00% | 29 Jan. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 441.799 | 7.1 | 0.080 | 7.18 | 1 | -1.11% | -0.56% | 33.21% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 441.799 | 1.05 | 0.030 | 1.08 | 1 | -2.78% | -2.78% | 40.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 441.799 | 4.58 | 0.090 | 4.67 | 1 | -1.93% | -3.58% | 41.80% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1119068000 | Nvidia | Constant Leverage | Long | ― | 158.259 | 106.57 | 0.220 | 106.79 | 1 | -0.21% | 13.12% | 42.70% | 12 May. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1199369815 | Nvidia | Constant Leverage | Long | ― | 158.259 | 14.76 | 0.030 | 14.79 | 1 | -0.20% | 16.31% | 54.72% | 27 Jun. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1246614460 | Nvidia | Constant Leverage | Long | ― | 158.259 | 2.19 | 0.010 | 2.2 | 1 | -0.45% | 19.02% | 65.91% | 3 Feb. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1246615640 | Nvidia | Constant Leverage | Long | ― | 158.259 | 0.4 | 0.010 | 0.41 | 1 | -2.44% | 14.29% | 53.85% | 8 Jun. 2023 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.